|
|
Molecular Targeted Therapeutics Market Research Reports
 | |  |
| |
We offer market research, industry forecasts, and business analysis in the Molecular Targeted Therapeutics Market as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, such as industry forecasts, projections, trends, market shares, research and development, sales and marketing strategies, and competitive analysis. The easiest way to find out if we have the information you need is to contact us right now. We are open 24 hours a day, 5 days a week with multiple language support. Please see our Contact page to see which office is open right now.
|
|
 | |  |
| CDK Inhibitor Patent Landscape 2009 |
|
| Table of Contents Published: 2009/11 Published by: France Innovation Scientifique et Transfert (FIST SA) |
| Regulating cell function by controlling cell pathways is an important strategy in the development of agents for the treatment of cancer and numerous other diseases. Protein kinases are a family of enzymes involved in the regulation of almost all cell proc ... |
| Molecular Targeted Cancer Therapies Market Forecast |
|
| Table of Contents Published: 2009/08 Published by: Datamonitor |
| Molecular targeted cancer therapies are the biggest and fastest growing class of cancer drugs in terms of sales. As growth of revenues from cytotoxic therapies and antihormonal therapies has slowed and many key brands in these classes face imminent patent ... |
| Competitor Analysis: Targeted Therapy of Hepatitis C |
|
| Table of Contents Published: 2009/08 Published by: La Merie |
| The present Competitive Intelligence Report about Targeted Therapy of Hepatitis C provides a competitor evaluation in the field of specifically targeted antiviral therapeutics for hepatitis C (STAT-C) as of August 2009. Purchase of the downloadable pdf re ... |
| Small Molecule Kinase Inhibitors |
|
| Table of Contents Published: 2009/07 Published by: Global Industry Analysts, Inc. |
| This report analyzes the Global Market for Small Molecule Kinase Inhibitors in Millions of US$ by the following Product Segments: Gleevec/Glivec, Tarceva, Sutent, Nexavar, Sprycel, Iressa, Tykerb/Tyverb, and Others. ... |
| Apoptosis 2009: Opportunities in Cancer and Other Diseases |
|
| Table of Contents Published: 2009/02 Published by: Biophoenix Limited |
| Apoptosis is regarded as the major mode of cell death in cancer and should therefore be considered as a potential target when developing new antineoplastic drugs. An increasing number of companies are doing so, and we anticipate that this approach will pa ... |
| Protease Inhibitors: Innovation Drives Drug Pipeline |
|
| Table of Contents Published: 2009/02 Published by: Insight Pharma Reports |
| Proteases constitute one of the largest potential drug target enzyme families, with 647 human gene products incorporating protease sequences and mutated proteases having been identified. In addition, there are many more proteases found in viruses, bacteri ... |
| Analytical Tool - Apoptosis in Oncology |
|
| Published: 2009/01 Published by: BioSeeker Group AB |
| Analytical Tool - Apoptosis in Oncology offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in apoptopic drug development for the treatment of cancer. It is at the same time a map of the research and development ... |
| Analytical Tool - Protein Kinase Inhibitors in Oncology |
|
| Table of Contents Published: 2009/01 Published by: BioSeeker Group AB |
| Analytical Tool - Protein Kinase Inhibitors in Oncology offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in the drug development of protein kinase inhibitors (PKIs) for the treatment of cancer. It is at the s ... |
| Apoptosis in Oncology: Drug Pipeline Update 2009 |
|
| Table of Contents Published: 2009/01 Published by: BioSeeker Group AB |
| Cancer cells frequently and possibly invariably possess apoptotic defects. In this context, apoptotic pathways provide exciting molecular targets for new therapeutic agents to specifically promote apoptosis of cancer cells. ... |
| The World Market for Molecular Diagnostics |
|
| Table of Contents Published: 2009/01 Published by: Kalorama Information |
| The various clinical techniques and trends are discussed from the point of view of their present and potential market impact.
Market analysis in this report covers world markets for in vitro diagnostics, with focus on the developed areas of the globe ... |
| Targeting Kinases for Drug Discovery |
|
| Table of Contents Published: 2008/04 Published by: Decision Resources, Inc. |
| Protein kinases - intracellular enzymes that modulate cellular functions - play a pivotal role in the signal transduction processes that regulate many key biological processes. Abnormalities in these signal transduction pathways are implicated in the etio ... |
| The Drug Target Atlas of Apoptopic Drugs in Oncology |
|
| Table of Contents Published: 2008/02 Published by: BioSeeker Group AB |
| In the report, BioSeeker reports on 90 unique drug target combinations, each comprised of a different collection or mix of individually defined targets, for 114 apoptopic drugs designed for the treatment of 48 different cancer indications. The highest deg ... |
| Melanoma - Targeted Therapeutics |
|
| Table of Contents Published: 2007/07 Published by: BioSeeker Group AB |
| The risk of malignant melanoma has more than doubled in the past decade. The incidence of melanoma is rising faster than that of any other cancer. ... |
| Antibody Drug Target Atlas in Oncology |
|
| Table of Contents Published: 2007/06 Published by: BioSeeker Group AB |
| The elaborate advances towards the blueprinting of the altered molecular networks that lie behind cancer development have paved the way for targeted therapy in cancer. ... |
| Oncology Pipelines: Is the Future Targeted Therapy? |
|
| Table of Contents Published: 2007/05 Published by: Decision Resources, Inc. |
| Drug companies' cancer pipelines are bulging, and hundreds of new drugs are in development-the modern equivalent of a gold rush. Remarkable successes have been recorded with targeted oncology, but the treatment of more than 200 types of cancer remains a d ... |
| Targeted Therapeutics in Non-Small Cell Lung Cancer |
|
| Table of Contents Published: 2007/04 Published by: BioSeeker Group AB |
| Lung cancer is the third most common malignant disease and the first leading cause of cancer death in the western world. Yet platinum agent constitutes the current mainstay of front-line metastatic lung cancer treatment. There are currently two platinum-b ... |
| Competitive Outlook on Apoptosis in Oncology |
|
| Table of Contents Published: 2006/12 Published by: BioSeeker Group AB |
| Cancer cells frequently and possibly invariably possess apoptotic defects. In this context, apoptotic pathways provide exciting molecular targets for new therapeutic agents to specifically promote apoptosis of cancer cells ... |
|
|
|
View Cart
